Cargando…
Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
Autores principales: | de Salazar Alcalá, Andrea García, Gioda, Lucile, Dehman, Alia, Beugnet, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796375/ https://www.ncbi.nlm.nih.gov/pubmed/31619253 http://dx.doi.org/10.1186/s12917-019-2116-1 |
Ejemplares similares
-
Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
por: de Salazar Alcalá, Andrea García, et al.
Publicado: (2019) -
Grapiprant: A snapshot of the current knowledge
por: Sartini, Irene, et al.
Publicado: (2021) -
Correction to: The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
por: Vijarnsorn, Monchanok, et al.
Publicado: (2020) -
Analgesic efficacy of oral firocoxib in ovariohysterectomized cats
por: Phuwapattanachart, Prangtip, et al.
Publicado: (2017) -
Cutaneous adverse drug reaction in a dog following firocoxib treatment
por: Geum, Migyeong, et al.
Publicado: (2021)